Maxim Group set a $5.00 target price on Amedica Corp. (NASDAQ:AMDA) in a research note released on Thursday. The firm currently has a buy rating on the stock.

Amedica Corp. (NASDAQ:AMDA) opened at 0.677 on Thursday. The stock’s market cap is $17.87 million. Amedica Corp. has a 52 week low of $0.60 and a 52 week high of $3.62. The company has a 50 day moving average price of $0.77 and a 200 day moving average price of $0.97.

COPYRIGHT VIOLATION NOTICE: This news story was published by Daily Political and is the propert of of Daily Political. If you are viewing this news story on another site, it was illegally stolen and republished in violation of international copyright laws. The correct version of this news story can be viewed at http://www.dailypolitical.com/2016/11/30/amedica-corp-amda-given-a-5-00-price-target-by-maxim-group-analysts.html.

Amedica Corp. Company Profile

Amedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty.

5 Day Chart for NASDAQ:AMDA

Receive News & Ratings for Amedica Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedica Corp. and related companies with MarketBeat.com's FREE daily email newsletter.